Enzo CEO: Clinical Business Heating Up, Patents Wins Will Continue
( 02:34 )
+ ADD TO MY LIST
- REMOVE FROM MY LIST
+ ADD TO MY LIST
- REMOVE FROM MY LIST

61 views

VIDEO DESCRIPTION:

Shares of Enzo Biochem have been flying over the past year due to increased demand for its clinical products, successful patent resolutions and new product introductions, says the company's president Barry Weiner. Enzo recently pocketed a multi-million dollar settlement from Affymetrix and Weiner expects the successful legal resolutions to continue without disrupting the ongoing business.

+ ADD TO MY LIST
- REMOVE FROM MY LIST
+ ADD TO MY LIST
- REMOVE FROM MY LIST
Add to My List Remove from My List

Added to My List

Removed from My List

Did you know?
By signing up, you can access your watch list and history across your other devices including mobile, tablet and Connected TV.
You can

It only takes a few seconds!

Did you know?
By signing up, you can access your watch list and history across your other devices including mobile, tablet and Connected TV.
You can

It only takes a few seconds!